Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Colin Goddard
AddedMar 31, 2024
UpdatedMay 31, 2026
Colin Goddard

Colin Goddard

Board Member, Human Genome Sciences

CrunchbaseLinkedIn

Colin Goddard's Career

Human Genome Sciences
Human Genome Sciences

Rockville, MD, US

Board Member· Board
Coferon
Coferon

Stony Brook, NY, US

CEO· C-Suite · Management
BlinkBio
BlinkBio

Jupiter, FL, US

Board Member· Board
Merganser Biotech
Merganser Biotech

Newtown Square, PA, US

Board Member· Board
HiberCell
HiberCell

New York City, NY, US

Board Member· Board
PanOptica
PanOptica

Mount Arlington, NJ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Colin Goddard's Career

Human Genome Sciences
Human Genome Sciences
Acquired01992Rockville, MD, US
Board Member· Board

Leadership at Human Genome Sciences

J. Craig VenterJ. Craig VenterFounder
Jerry KarabelasJerry KarabelasBoard Member
Allan BaxterAllan BaxterBoard Member

Similar to Human Genome Sciences

GSKGSKLondon, Greater London, GBBiotech, Pharmaceuticalsest. 2000GSKLondon, Greater London, GB · est. 2000

GSK PLC: A British multinational firm innovating in pharmaceuticals, biotech, and health products.

Public · $25.5M69.4k
Gilead SciencesGilead SciencesFoster City, CA, USPharmaceuticals, Therapiesest. 1987Gilead SciencesFoster City, CA, US · est. 1987

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.

Public · $2B17k
GeneDx HoldingsGeneDx HoldingsStamford, CT, USGenetic Testingest. 2017GeneDx HoldingsStamford, CT, US · est. 2017

Connecticut-based GeneDx, a software company merging diagnostics and data science for personalized health insights.

Public · $941M919
Gene SciencesGene SciencesSan Diego, CA, USTherapeuticsest. 2016Gene SciencesSan Diego, CA, US · est. 2016

Gene Sciences, Inc.: A US-based biotech company specializing in DNA-targeted therapeutics.

Public · $8M6
Coferon
Coferon

Stony Brook, NY, US

CEO· C-Suite · Management
BlinkBio
BlinkBio

Jupiter, FL, US

Board Member· Board
Merganser Biotech
Merganser Biotech

Newtown Square, PA, US

Board Member· Board
HiberCell
HiberCell
Series C$158.2M872019New York City, NY, US
Board Member· Board

Leadership at HiberCell

Ari NowacekAri NowacekCo-Founder
Alan RigbyAlan RigbyCo-Founder
Jonathan LanfearJonathan LanfearCEO
Julio Aguirre-GhisoJulio Aguirre-GhisoCo-Founder
Cindy JacobsCindy JacobsBoard Member
Steve GillisSteve GillisBoard Member

Similar to HiberCell

HebeCellHebeCellNatick, MA, USCell Therapiesest. 2016HebeCellNatick, MA, US · est. 2016

MA-based HebeCell pioneers in immuno-oncology and regenerative medicine through cell-based therapeutics.

Series A · $63M24
CellvieCellvieHouston, TX, USMitochondria Therapiesest. 2018CellvieHouston, TX, US · est. 2018

Cellvie: Developing cell-derived medicines by leveraging the therapeutic potential of mitochondria to treat ischemia-reperfusion injuries.

Seed · $10.5M9
HibernaidHibernaidTroy, NY, USMedical Therapiesest. 2011HibernaidTroy, NY, US · est. 2011

Hibernaid: A private firm developing unique acute medical therapies for high-risk critical care patients.

Angel · $100k5
PanOptica
PanOptica

Mount Arlington, NJ, US

Board Member· Board

Colin Goddard's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Colin Goddard

Michael E. GarganoMichael E. GarganoCo-Founder · BlinkBioDon BergstromDon BergstromCo-Founder · BlinkBioMatthew CraigMatthew CraigCo-Founder · BlinkFrancis BaranyFrancis BaranyCo-Founder · BlinkBioRyan FioriniRyan FioriniFounder · BlinktbiSean NolanSean NolanFounder · Blink